The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A tumor growth rate/overall survival model for atezolizumab as an early predictor of OS in patients with first or second line metastatic urothelial carcinoma.
 
Rene Bruno
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Laurent Claret
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Benjamin Wu
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Jin Y Jin
Employment - Acerta Pharma (I); Genentech/Roche; Theravance (I)
Stock and Other Ownership Interests - Genentech/Roche; Gilead Sciences (I); Lilly
Consulting or Advisory Role - Polaris Consulting (I)
 
Helen Winter
Employment - Genentech/Roche
Stock and Other Ownership Interests - AstraZeneca; Pfizer; Roche
 
Na Cui
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Christina Louise Derleth
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Xiaodong Shen
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Sandhya Girish
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - AstraZeneca; Bristol-Myers Squibb; Medscape; Peerview; UpToDate; Vindico
Consulting or Advisory Role - Agensys; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; EMD Serono; Inovio Pharmaceuticals; Lilly; Merck; Roche/Genentech; Sanofi; Seagen
Research Funding - Agensys (Inst); Genentech (Inst); Genentech/Roche (Inst); Incyte; Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - Predictor of platinum sensitivity (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; MERCK; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Ipsen